Europe Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
The European generics market had total revenues of $81.3 billion in 2022, representing a compound annual growth rate (CAGR) of 5.7% between 2017 and 2022.
Market consumption volume increased with a CAGR of 2% between 2017 and 2022, to reach a total of 56.3% in 2022.
In 2022, the European generics market witnessed an annual growth of 6.8% due to the increase in prices of generics in countries such as Germany and the UK owing to the shortage of generic medicines
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Europe
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Europe generics market with five year forecasts by both value and volume
Reasons to Buy
What was the size of the Europe generics market by value in 2022?
What will be the size of the Europe generics market in 2027?
What factors are affecting the strength of competition in the Europe generics market?
How has the market performed over the last five years?
Who are the top competitors in Europe's generics market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Pfizer Inc.
8.4. Sanofi SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Europe generics market value: $ million, 2017-22
Table 2: Europe generics market volume: %, 2017-22
Table 3: Europe generics market geography segmentation: $ million, 2022
Table 4: Europe generics market value forecast: $ million, 2022-27
Table 5: Europe generics market volume forecast: %, 2022-27